Omada Health (NASDAQ:OMDA) CFO Steven Cook Sells 17,950 Shares

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 17,950 shares of the firm’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $18.13, for a total transaction of $325,433.50. Following the sale, the chief financial officer owned 169,259 shares in the company, valued at approximately $3,068,665.67. This trade represents a 9.59% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Omada Health Stock Performance

NASDAQ OMDA opened at $18.58 on Thursday. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The company has a fifty day moving average of $16.22 and a 200-day moving average of $14.79. The company has a market capitalization of $1.10 billion and a P/E ratio of -68.81.

Omada Health (NASDAQ:OMDA) last released its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The business had revenue of $78.05 million for the quarter. As a group, analysts forecast that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Institutional Investors Weigh In On Omada Health

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Raymond James Financial Inc. bought a new position in Omada Health during the 2nd quarter worth approximately $32,000. Quarry LP bought a new stake in Omada Health in the fourth quarter valued at approximately $29,000. TD Waterhouse Canada Inc. purchased a new stake in shares of Omada Health during the fourth quarter valued at approximately $32,000. Inlight Wealth Management LLC bought a new position in shares of Omada Health in the fourth quarter worth approximately $45,000. Finally, JPMorgan Chase & Co. purchased a new position in shares of Omada Health in the third quarter worth $82,000.

Analyst Ratings Changes

A number of brokerages recently weighed in on OMDA. JPMorgan Chase & Co. decreased their price objective on Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a report on Thursday, March 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Omada Health in a research report on Thursday, June 4th. Citizens Jmp lifted their price target on shares of Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research note on Friday, May 8th. Barclays boosted their price objective on shares of Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, May 8th. Finally, Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a research note on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.